Haring R, Stanton PK, Scheideler MA, Moskal JR (1991). «Glycine-like modulation of N-methyl-D-aspartate receptors by a monoclonal antibody that enhances long-term potentiation». J. Neurochem.57 (1): 323-32. PMID1828831. S2CID37941813. doi:10.1111/j.1471-4159.1991.tb02131.x.
Moskal JR, Kuo AG, Weiss C, Wood PL, O'Connor Hanson A, Kelso S, Harris RB, Disterhoft JF (2005). «GLYX-13: a monoclonal antibody-derived peptide that acts as an N-methyl-D-aspartate receptor modulator». Neuropharmacology49 (7): 1077-87. PMID16051282. S2CID7372648. doi:10.1016/j.neuropharm.2005.06.006.
Moskal, Joseph R.; Kuo, Amy G.; Weiss, Craig; Wood, Paul L.; O'Connor Hanson, Amy; Kelso, Stephen; Harris, Robert B.; Disterhoft, John F. (2005). «GLYX-13: A monoclonal antibody-derived peptide that acts as an N-methyl-d-aspartate receptor modulator». Neuropharmacology49 (7): 1077-87. PMID16051282. S2CID7372648. doi:10.1016/j.neuropharm.2005.06.006.
Stanton, Patric K.; Potter, Pamela E.; Aguilar, Jennifer; Decandia, Maria; Moskal, Joseph R. (2009). «Neuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13». NeuroReport20 (13): 1193-7. PMID19623090. S2CID6269255. doi:10.1097/WNR.0b013e32832f5130.
Stanton, Patric K.; Potter, Pamela E.; Aguilar, Jennifer; Decandia, Maria; Moskal, Joseph R. (2009). «Neuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13». NeuroReport20 (13): 1193-7. PMID19623090. doi:10.1097/WNR.0b013e32832f5130.
Haring R, Stanton PK, Scheideler MA, Moskal JR (1991). «Glycine-like modulation of N-methyl-D-aspartate receptors by a monoclonal antibody that enhances long-term potentiation». J. Neurochem.57 (1): 323-32. PMID1828831. S2CID37941813. doi:10.1111/j.1471-4159.1991.tb02131.x.
Moskal JR, Kuo AG, Weiss C, Wood PL, O'Connor Hanson A, Kelso S, Harris RB, Disterhoft JF (2005). «GLYX-13: a monoclonal antibody-derived peptide that acts as an N-methyl-D-aspartate receptor modulator». Neuropharmacology49 (7): 1077-87. PMID16051282. S2CID7372648. doi:10.1016/j.neuropharm.2005.06.006.
Moskal, Joseph R.; Kuo, Amy G.; Weiss, Craig; Wood, Paul L.; O'Connor Hanson, Amy; Kelso, Stephen; Harris, Robert B.; Disterhoft, John F. (2005). «GLYX-13: A monoclonal antibody-derived peptide that acts as an N-methyl-d-aspartate receptor modulator». Neuropharmacology49 (7): 1077-87. PMID16051282. S2CID7372648. doi:10.1016/j.neuropharm.2005.06.006.
Stanton, Patric K.; Potter, Pamela E.; Aguilar, Jennifer; Decandia, Maria; Moskal, Joseph R. (2009). «Neuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13». NeuroReport20 (13): 1193-7. PMID19623090. S2CID6269255. doi:10.1097/WNR.0b013e32832f5130.
Stanton, Patric K.; Potter, Pamela E.; Aguilar, Jennifer; Decandia, Maria; Moskal, Joseph R. (2009). «Neuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13». NeuroReport20 (13): 1193-7. PMID19623090. doi:10.1097/WNR.0b013e32832f5130.
Haring R, Stanton PK, Scheideler MA, Moskal JR (1991). «Glycine-like modulation of N-methyl-D-aspartate receptors by a monoclonal antibody that enhances long-term potentiation». J. Neurochem.57 (1): 323-32. PMID1828831. S2CID37941813. doi:10.1111/j.1471-4159.1991.tb02131.x.
Moskal JR, Kuo AG, Weiss C, Wood PL, O'Connor Hanson A, Kelso S, Harris RB, Disterhoft JF (2005). «GLYX-13: a monoclonal antibody-derived peptide that acts as an N-methyl-D-aspartate receptor modulator». Neuropharmacology49 (7): 1077-87. PMID16051282. S2CID7372648. doi:10.1016/j.neuropharm.2005.06.006.
Moskal, Joseph R.; Kuo, Amy G.; Weiss, Craig; Wood, Paul L.; O'Connor Hanson, Amy; Kelso, Stephen; Harris, Robert B.; Disterhoft, John F. (2005). «GLYX-13: A monoclonal antibody-derived peptide that acts as an N-methyl-d-aspartate receptor modulator». Neuropharmacology49 (7): 1077-87. PMID16051282. S2CID7372648. doi:10.1016/j.neuropharm.2005.06.006.
Stanton, Patric K.; Potter, Pamela E.; Aguilar, Jennifer; Decandia, Maria; Moskal, Joseph R. (2009). «Neuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13». NeuroReport20 (13): 1193-7. PMID19623090. S2CID6269255. doi:10.1097/WNR.0b013e32832f5130.